AnPac Bio-Medical Science Announces Closing of $3.0 Million Registered Direct Offering

Stock Information for AnPac Bio-Medical Science Co. Ltd.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About AnPac Bio-Medical Science Co. Ltd.

Fresh2 Group Ltd. Announces Nasdaq Ticker Symbol Change from 'ANPC' to 'FRES'
Fresh2 Files Annual Report on Form 20-F for Fiscal Year 2022
Fresh2 Reports Fiscal Year 2022 Annual Financial Results
Fresh2 Reports First Quarter of Fiscal Year 2023 Financial Results
Univest Securities, LLC Announces Closing of $3.0 Million Registered Direct Offering for its Client AnPac Bio-Medical Science Co., Ltd. (NASDAQ: ANPC)
AnPac Bio-Medical Science Enters into Asset Purchase Agreement with Easy Hundred Inc.
AnPac Bio-Medical Science Announces Pricing of $3.0 Million Registered Direct Offering
AnPac Bio-Medical Science Granted Continued Listing by NASDAQ Hearing Panel, Subject to Meeting the Equity Rule on or before July 12, 2023

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.